A Second COVID-19 Vaccine Trial Has Been Paused Over an Unexplained Illness

NEW BRUNSWICK, N.J. — A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot. The company said in a statement Monday evening that illnesses, accidents and other so-called adverse events “are an expected part of any clinical … Read more